30/4/2025, 3:55:04 pm

Ajanta Pharma Q4 Results: Profit, revenue rise 11%; margin contracts

Ajanta Pharma reported an 11% year-on-year rise in profit at ₹225 crore for Q1 FY2025, with revenue increasing 11% to ₹1,170 crore. EBITDA grew 7% to ₹297 crore, with a 25% margin. The company distributed ₹700 crore, representing 76% of its PAT. Shares closed 2.74% lower at ₹2,690, down 10% year-to-date in 2025.